News

Winner of 2014 Bloomberg Manulife Prize

$50,000 research award to promote active health goes to Dr. David J.A. Jenkins – inventor of the glycemic index and inspiration behind low-cholesterol diets
Published: 11 December 2014

McGill University, in association with Lawrence and Frances Bloomberg and Manulife, is pleased to announce that David J.A. Jenkins, University Professor and Canada Research Chair in Nutrition and Metabolism at the University of Toronto, Department of Nutritional Sciences, Director of the Risk Factor Modification Centre and Scientist at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, is the winner of the 2014 Bloomberg Manulife Prize for the Promotion of Active Health.

Dr. Jenkins, the first Canadian to win the prize, has dedicated his career to understanding the nutritional value of foods and to helping people make healthy eating choices that can lower cholesterol and blood glucose, prevent chronic disease and provide long-term health benefits. His groundbreaking research led to the development of the glycemic index, a revolutionary tool which identifies the glycemic effect of carbohydrate foods, leading to the creation of diets that can effectively treat chronic diseases such as diabetes and heart disease.

The $50,000 Bloomberg Manulife Prize was founded in May 2011 by McGill University alumnus and Toronto-based investment manager Lawrence S. Bloomberg, C.M., O.Ont., MBA‘65 and corporate sponsor Manulife Financial. The annual award is given to a researcher whose work has broadened our understanding of how physical activity, nutrition or psychosocial factors influence personal health and wellbeing. Applications for the Prize are judged by a jury of distinguished academics from universities and research institutions across North America.

“The Bloomberg Manulife Prize was created to raise the profile of health research that is a catalyst for real and lasting change to our wellbeing and the way we live,” explains Mr. Bloomberg. “I am delighted that this year the Prize is recognizing a prominent Canadian researcher who has not only made pioneering discoveries that have changed how we view nutrition but who has made public advocacy and education a centerpiece of his work.”

"Dr. Jenkins is a leader in his field and has made significant contributions to the study of Nutritional Sciences,” says Marianne Harrison, Senior Executive Vice President & General Manager, Canadian Division at Manulife. "We at Manulife are proud to support this award that recognizes his forward-thinking work in the study of nutrition and the promotion of healthy living."

Dr. Jenkins’ influence extends well beyond the laboratory; his research has informed global dietary guidelines, including those of the Diabetes Federation and the World Health Organization, influencing the treatment of approximately 115 million individuals worldwide. As an advocate for healthy and sustainable eating, he has represented the medical community on Agriculture Canada’s Science Advisory Board and has partnered with grocers such as Loblaw Companies, inspiring them to produce a line of foods that are beneficial to cardiovascular health.

Since its inauguration, the Prize has gained the endorsement of prominent health organizations including The Canadian Cancer Society, The Canadian Heart and Stroke Foundation, ParticipACTION Canada, The Canadian Diabetes Association and YMCA Canada.

Dr. Jenkins will accept the prize at a special ceremony at the MaRS Centre in Toronto on Monday, January 19, where he will also take part in a conversation about his research. This will be followed by a moderated discussion on Wednesday, January 21 at McGill University in Montreal, to discuss how small changes in our diet can prevent chronic disease, lower cholesterol levels and provide long-term cardiovascular benefits.

About the Bloomberg Manulife Prize

The Bloomberg Manulife Prize is administered by McGill's Faculty of Education. Sponsors include The Globe and Mail, Shaw Media, Cineplex Odeon, and the Cambridge Group of Clubs.

For more information: www.mcgill.ca/bloomberg-manulife

About Manulife

Manulife is a leading Canada-based financial services group with principal operations in Asia, Canada and the United States. We operate as John Hancock in the U.S. and as Manulife in other parts of the world. We provide strong, reliable, trustworthy and forward-thinking solutions for our customers’ significant financial decisions. Our international network of employees, agents and distribution partners offers financial protection and wealth management products and services to millions of clients. We also provide asset management services to institutional customers. Funds under management by Manulife and its subsidiaries were approximately C$663 billion (US$591 billion) as at September 30, 2014.


Manulife Financial Corporation trades as ‘MFC’ on the TSX, NYSE and PSE, and under ‘945’ on the SEHK. Manulife can be found on the Internet at manulife.com

 

 

 

Back to top